Compass Therapeutics
Stock Forecast, Prediction & Price Target
Compass Therapeutics Financial Estimates
Compass Therapeutics Revenue Estimates
Compass Therapeutics EBITDA Estimates
Compass Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $5.32M Low: $3.51M High: $7.14M avg. 0% | Avg: $69.08M Low: $45.56M High: $92.60M avg. 1196.46% | Avg: $207.61M Low: $136.92M High: $278.30M avg. 200.53% | Avg: $362.62M Low: $239.15M High: $486.08M avg. 74.65% |
Net Income
% change YoY
| $-82.55M N/A | $-36.79M 55.42% | $-42.49M -15.48% | Avg: $-71.37M Low: $-86.37M High: $-33.02M avg. -67.96% | Avg: $-45.24M Low: $-74.94M High: $35.56M avg. 36.60% | Avg: $13.71M Low: $7.64M High: $19.79M avg. 130.31% | Avg: $97.81M Low: $54.51M High: $141.10M avg. 612.96% |
EBITDA
% change YoY
| $-29.61M N/A | $-37.39M -26.27% | $-48.47M -29.63% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.31 N/A | -$0.35 73.28% | -$0.33 5.71% | Avg: -$0.44 Low: -$0.68 High: -$0.26 avg. -32.03% | Avg: -$0.26 Low: -$0.59 High: $0.28 avg. 40.32% | Avg: $0.11 Low: $0.06 High: $0.16 avg. 141.53% | Avg: $0.77 Low: $0.43 High: $1.11 avg. 612.96% |
Operating Expenses
% change YoY
| $31.26M N/A | $41.65M 33.23% | $48.47M 16.36% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Compass Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 177.98% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -86.37M, average is -71.37M and high is -33.02M.
What is Compass Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 367.91% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $3.51M, average is $5.32M and high is $7.14M.
What is Compass Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 190.69% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$0.68, average is -$0.44 and high is $-0.26.